Takeda logo

Meet the Takeda Global Oncology Leadership Team | Takeda Oncology

Takeda Global Oncology Leadership Team

#

Comprised of Takeda's global oncology commercial operations, Takeda Oncology operates in close alignment with Takeda's dedicated global oncology R&D function, the Oncology Therapeutic Area Unit (OTAU), to address unmet patient needs, move the company's products forward, and to maintain a focus on expanding our oncology pipeline.

Takeda Oncology leadership team is comprised of the following functions and led by the following individuals:

Team Profile Card Section

altText of the image

Teresa Bitetti

President, Global Oncology Business Unit

Phuong Khanh Morrow

Phuong Khanh (P.K.) Morrow, M.D.

Head, Oncology Therapeutic Area Unit

Leadership

Ana Cardoso

Ana Cardoso

Head, Human Resources Global Oncology Business Unit

Mario Damo

Mario Damo

Chief Financial Officer, Global Oncology Business Unit

Annarita Egidi

Annarita Egidi

Head, Europe and Canada Oncology Business Unit

altText of the image

Awny Farajallah, M.D.

Chief Medical Officer, Global Oncology Business Unit

altText of the image

Pallavi Garg

Head, Global Oncology Products and Pipeline Strategy

altText of the image

Stefanie Granado, Ph.D.

Head, US Oncology Business Unit

Sascha Haverfield

Sascha Haverfield

Head, Strategy and Operations, Oncology Therapeutic Area Unit

John Huber, Ph.D.

John Huber, Ph.D.

Head, Global Regulatory Affairs, Oncology

altText of the image

Liz Lewis

Head, Global Oncology Patient Value, Policy, and Access

altText of the image

Cristin McArdle

Head Counsel,Global Oncology Business Unit

altText of the image

Ana Paula Neves

Head, E&C, Global Oncology Business Unit

altText of the image

Rosa Notaroberto

Head, Business Operations,Global Oncology Business Unit

Satoshi Uchida

Satoshi Uchida

Head, Japan Oncology Business Unit

All trademarks are the property of their respective owners.

©2024 Takeda Pharmaceuticals U.S.A., Inc.

All rights reserved.   01/23